US loss of exclusivity · Immunology
Simponi
Johnson & Johnson
2026
US biosimilars from
2025
Today: 2026
2037
2025 worldwide sales
$2.7B
Date basis
Company guidance
US biosimilars
Approved, waiting to launch
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Simponi timeline →